35 results on '"Zanotti, Lucia"'
Search Results
2. Role of epigenetics in the clinical evolution of COVID-19 disease. Epigenome-wide association study identifies markers of severe outcome
3. RESIDENCE AT HIGH ALTITUDE IS ASSOCIATED WITH LOWER CONVENTIONAL AND AMBULATORY BLOOD PRESSURE THAN LIVING AT SEA LEVEL IN THE GENERAL POPULATION OF PERU. HIGHCARE-LAPS STUDY
4. Reboxetine Plus Oxybutynin for OSA Treatment: A 1-Week, Randomized, Placebo-Controlled, Double-Blind Crossover Trial
5. Proteomic analysis of the secretome of human bone marrow-derived mesenchymal stem cells primed by pro-inflammatory cytokines
6. Data from Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
7. Effect of fetal bovine serum in culture media on MS analysis of mesenchymal stromal cells secretome
8. The Neural Stem Cells
9. A
10. Abstract LB563: Integrated multiomic profiling identifies the epigenetic regulator PRC2 as a therapeutic target to counteract leukemia immune escape and relapse
11. Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial
12. Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
13. Reboxetine plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-week Randomized, Placebo-controlled, Double-Blind Crossover Trial
14. Rationale for the use of neural stem/precursor cells in immunemediated demyelinating disorders
15. Reboxetine Plus Oxybutynin for Obstructed Sleep Apnea Treatment A 1-Week Randomized, Placebo-Controlled, Double-Blind Crossover Trial
16. Neurosphere-derived multipotent precursors promote neuroprotection by an immunomodulatory mechanism
17. Integrated Epigenetic Profiling Identifies EZH2 As a Therapeutic Target to Re-Establish Immune Recognition of Leukemia Relapses with Loss of HLA Class II Expression
18. Additional file 2: Figure S2. of 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
19. Additional file 1: Figure S1. of 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
20. Additional file 3: Figure S3. of 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
21. Combining Whole Exome Sequencing and Rnaseq to Provide a Comprehensive Landscape of the Mechanisms of Post-Transplantation Leukemia Relapse
22. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis
23. Clinical and Biological Features Associated with Engraftment of Acute Myeloid Leukemia Patient-Derived Xenografts
24. CCRL2 regulates M1/M2 polarization during EAE recovery phase
25. Endothelial cells: new targets for MSCs-mediated immunomodulation in mouse
26. Mesenchymal Stem Cells Reduce Colitis in Mice via Release of TSG6, Independently of Their Localization to the Intestine
27. Autoimmune Demyelinating Disorders: Stem Cell Therapy
28. Immune Regulatory Neural Stem/Precursor Cells Protect from Central Nervous System Autoimmunity by Restraining Dendritic Cell Function
29. Regeneration and repair in multiple sclerosis: The role of cell transplantation
30. Neural stem cells and their use as therapeutic tool in neurological disorders
31. Reboxetine Plus Oxybutynin for OSA Treatment
32. 18F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis.
33. Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse
34. 18 F-VC701-PET and MRI in the in vivo neuroinflammation assessment of a mouse model of multiple sclerosis.
35. Mesenchymal stem cells: myths and reality.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.